Monday, 19 December 2011 11:36
Three United States Senators have sent Medtronic a letter, asking for information about how it tracks medical devices after releasing them on the market, according to a Star Tribune report.
Wednesday, 14 December 2011 15:53
Share prices for orthopedic and spine device companies have been on the downturn since last weekend, when the Centers for Medicare and Medicaid Services released a new pre-reimbursement review project, according to a Mass Device report.
Wednesday, 07 December 2011 13:32
The Oregon Evidence-based Practice Center at Oregon Health & Sciences University in Portland has been selected as one of two research centers that will independently review clinical studies on rhBMP-2, according to an OHSU news release.
Wednesday, 30 November 2011 11:38
Medtronic recently launched its T2 Altitude Expandable Corpectomy Device in the United States and Europe, according to a Medtronic news release.
Tuesday, 22 November 2011 10:03
Medtronic recently reported second quarter revenue of $4.1 billion, a 6 percent increase over the second quarter of last year, according to a Medtronic news release.
Thursday, 17 November 2011 14:39
The FDA approved Medtronic's AdaptiveStim with the RestoreSensor neurostimulation system, according to a Medtronic news release.
Published in Pain Management
Tuesday, 08 November 2011 12:33
A study led by Eugene Carragee, MD, recently presented at the North American Spine Society annual meeting, examined 12 industry-sponsored studies on the safety and efficacy of recombinant bone morphogenic protein-2 and found that no adverse events were reported in any of the studies.
Friday, 04 November 2011 12:41
Medtronic has launched its T2 Altitude Expandable Corpectomy Device in the United States and Europe, according to a Medtronic news release.
Tuesday, 25 October 2011 12:30
Eight leading spine surgeons and industry experts discuss Medtronic's recombinant bone morphogenic-2 product Infuse and how the recent controversy over complication disclosures is impacting its use.
Tuesday, 25 October 2011 11:01
Companies & Markets released a report forecasting growth in the spinal surgery device market to reach $12.6 billion by 2017 at a CAGR of 10 percent.